baber/WOPTO huggingface dataset:
Patent WO-2023087028-A1 (WO)
Inventor: JOHNSON ROLLAND PAUL
IPC: G21C1/22
Filed: 2022-11-15
Abstract: Un exemple pour l'élimination continue de produits de fission d'un réacteur nucléaire alimenté par sel fondu enfermés dans une enceinte de confinement de réacteur peut comprendre la séparation d'actinides provenant d'autres produits de fission s'écoulant hors du réacteur, le renvoi des actinides séparés vers le réacteur en vue de leur consommation, ainsi que l'élimination des autres produits de fission hors de l'enceinte de confinement pendant le fonctionnement du réacteur. Dans divers modes de réalisation, le réacteur peut être un réacteur critique, un réacteur sous-critique (par exemple, un entraînement d'accélérateur), ou un autre type de réacteur.
Patent WO-2023122441-A1 (WO)
Inventor: MAHBUB UPAL
IPC: G06V10/25
Filed: 2022-12-09
Abstract: L'invention concerne des procédés, des systèmes et des appareils pour détecter automatiquement des objets dans des images. Par exemple, un dispositif de capture d'image peut capturer une image, et peut appliquer un réseau neuronal formé à l'image pour générer une valeur d'objet et une valeur de classe pour chacune d'une pluralité de parties de l'image. En outre, le dispositif de capture d'image peut déterminer, pour chacune de la pluralité de parties d'image, une valeur de confiance sur la base de la valeur d'objet et de la valeur de classe correspondant à chaque partie d'image. Le dispositif de capture d'image peut également détecter un objet dans au moins une partie d'image sur la base des valeurs de confiance. En outre, le dispositif de capture d'image peut délivrer une boîte de délimitation correspondant à la ou aux parties d'image. La boîte de délimitation définit une zone de l'image qui comprend un ou plusieurs objets.
Patent WO-2023122521-A1 (WO)
Inventor: FAHEY BRIAN
IPC: A61F2/24
Filed: 2022-12-19
Abstract: The present technology is directed to implantable medical devices, systems, and methods for restricting, closing, or blocking an opening or defect in an anatomical structure. For example, many embodiments of the present technology are directed to implantable closure devices for plugging or sealing an opening in an anatomical structure separating a first body region and the second body region. In many of the embodiments described herein, the implantable closure devices are designed to be "recrossable," such that a catheter or other percutaneous tool can be passed through the closure device after the device has been implanted.
Patent WO-2023192037-A1 (WO)
Inventor: PHAM KHAI NHU
IPC: G06F21/55
Filed: 2023-03-17
Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for processing event log data. An example event log processing method includes receiving an event log comprising a plurality of event records describing events that have occurred on each of one or more computer systems over a period of time; converting the event log into a graph, comprising: normalizing the plurality of event records, including anonymizing a unique identifier value in each event record and replacing a variable value in each event record with a predetermined value; representing each normalized event record as one or more nodes in the graph; and generating a plurality of event clusters, wherein each event cluster includes an aggregated group of nodes and is generated based on common attributes of and hierarchical relationships between the normalized event records represented by the nodes in the aggregated group.
Patent WO-2023196115-A1 (WO)
Title: Colonne de faisceau d'électrons hybride miniature
Inventor: MURAY LAWRENCE
IPC: H01J37/141
Filed: 2023-03-21
Abstract: L'invention concerne une colonne de faisceau d'électrons miniature en combinaison avec des lentilles magnétostatiques pour produire des colonnes de faisceaux d'ions ou d'électrons miniatures à très haute performance. Des composants optiques électroniques à base de silicium constituent une formation et un alignement de haute précision d'éléments optiques critiques et les lentilles magnétiques constituent des éléments de focalisation ou de condensation à faible aberration. L'assemblage précis du silicium et des composants magnétiques peut être obtenu par l'intermédiaire des techniques d'assemblage multicouches et permet d'obtenir des performances élevées.
Patent WO-2023192177-A1 (WO)
Inventor: TIMKO MICHAEL T
IPC: C13K1/02
Filed: 2023-03-27
Abstract: An example method of hydrolyzing cellulose includes: providing cellulose to be hydrolyzed; applying a stabilizing salt to the cellulose to form a reaction mixture, the stabilizing salt configured to suppress recrystallization of amorphous cellulose in the reaction mixture; and hydrolyzing the amorphous cellulose in the presence of the stabilizing salt to suppress recrystallization of the amorphous cellulose in the reaction mixture during hydrolysis
Patent WO-2023201118-A1 (WO)
Title: Dispositifs microfluidiques à coins arrondis
Inventor: KIM JIHO
IPC: B01L3/00
Filed: 2023-04-17
Abstract: L'invention concerne un dispositif comprenant un substrat, et une ou plusieurs structures. Au moins une partie d'une surface inférieure de la ou des structures est accouplée au substrat, et la ou les structures comprennent une première partie définissant un premier réservoir et une seconde partie définissant un second réservoir qui est en communication avec le premier réservoir par l'intermédiaire d'un ou plusieurs canaux définis au moins entre le substrat et la ou les structures. La seconde partie de la ou des structures ne comprend pas de coin non arrondi qui s'étend de manière continue du substrat à une surface supérieure de la ou des structures.
Patent WO-2023220035-A1 (WO)
Title: Erythroparvovirus compositions and methods for gene therapy
Inventor: KOTIN ROBERT
IPC: A61K39/00
Filed: 2023-05-09
Abstract: Disclosed are recombinant virions that have a capsid protein or a variant thereof of erythroparvovirus and a nucleic acid that includes a heterologous nucleic acid.
Patent WO-2023239584-A1 (WO)
Inventor: EIDENSCHINK TRACEE
IPC: A61F2/24
Filed: 2023-06-01
Abstract: In some embodiments, a prosthetic heart valve system, includes a prosthetic heart valve including a stent, a cuff and a plurality of leaflets, the cuff and the plurality of leaflets forming a valve assembly, and the stent having one or more retention tabs, and a delivery device having an inner shaft and an expandable balloon transitionable between a deflated state and an inflated state, the delivery device having a hub with one or more receivers to accept the one or more retention tabs.
Patent WO-2023239751-A1 (WO)
Title: Système et procédé de réparation de valvule cardiaque
Inventor: BOYETTE JEREMY
IPC: A61F2/24
Filed: 2023-06-06
Abstract: Un dispositif de pose pour des implants de réparation de valvule cardiaque comprend un cathéter de pose et un élément d'extension faisant saillie à partir d'une extrémité distale du cathéter de pose. Le dispositif de pose comprend en outre un ensemble bras de commande ayant des paires de bras de commande. Chaque paire comprend un bras de commande proximal pouvant être entraîné à partir d'un ensemble poignée du dispositif de pose et un bras distal accouplé à une extrémité distale du bras de commande proximal et à une extrémité distale de l'élément d'extension. L'entraînement proximal de chacun des bras de commande proximaux de l'ensemble bras de commande entraîne l'expansion de l'ensemble bras de commande et l'expansion correspondante d'un implant de réparation de valvule cardiaque couplé à l'ensemble bras de commande.
Patent WO-2023250076-A1 (WO)
Title: Systems and methods for identifying medical conditions or treatment issues using optimized diabetes patient management data
Inventor: HODISH ISRAEL
IPC: A61K38/28
Filed: 2023-06-22
Abstract: Systems, methods and/or devices for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen. Also disclosed are systems, devices and/or methods for identifying medical conditions or diabetes treatment issues using systems, devices, and/or methods for optimizing a patient's insulin dosage regimen and/or other diabetes management data.
Patent WO-2023130141-A1 (WO)
Title: Compositions and methods for activating physiological health defenses
Inventor: LI WILLILAM W
IPC: A61K31/185
Filed: 2023-01-03
Abstract: The present invention provides compositions and methods for activating physiological health defenses. The invention, comprising combinations of, and methods of providing and administering, (1) anthocyanins; (2) β-(1-3,1-6)-D-glucan; (3) chlorogenic acid; (4) curcumin; (5) epigallocatechin-3-gallate (EGCG); (6) genistein; (7) hydroxytyrosol; (8) lycopene (including both cis- and trans- isomers); (9)  Lactobacillus reuteri ,  Akkermansia mucinophila , and/or  Ruminoccocus sp.  bacteria; (10) omega-3 polyunsaturated fatty acid (PUFA); (11) quercetin; and (12) proanthocyanidins, relieves and alleviates numerous deleterious health conditions and/or to support mammalian physiological health defenses including (but not limited to) angiogenesis, regeneration, microbiome, DNA protection, immunity, metabolism, and adaptive thermogenesis.
Patent WO-2023178004-A1 (WO)
Title: Stellarateur à bobine plane
Inventor: GATES DAVID
IPC: G21B1/05
Filed: 2023-03-08
Abstract: L'invention concerne un stellarator comprenant deux ensembles de bobines, à savoir un ensemble de bobines d'encerclement qui encerclent l'axe de plasma, et un ensemble de bobines de mise en forme qui n'encercle aucune autre bobine ou le plasma. Dans certains modes de réalisation, les bobines d'encerclement comprennent un élément structurel pour maintenir leur forme sous des forces magnétiques. Dans certains modes de réalisation, les bobines de mise en forme sont montées sur un ou plusieurs éléments structuraux qui, conjointement avec les bobines de mise en forme, constituent une unité de mise en forme de champ. L'invention concerne également un dispositif de commande qui peut modifier le courant électrique circulant dans un ou plusieurs sous-ensembles des bobines afin d'obtenir des paramètres de plasma cibles. L'invention concerne enfin un procédé de conception d'un ensemble de bobines de mise en forme par discrétisation d'un dipôle de surface ou d'une distribution de potentiel de courant.
Patent WO-2023205720-A1 (WO)
Inventor: RIDER JIMMY
IPC: B68C1/00
Filed: 2023-04-20
Abstract: Une boucle de niveau pour une selle Western comprend un manchon qui est réutilisable. Le manchon comprend des languettes pliables sur le revêtement métallique interne, de telle sorte que les languettes peuvent s'ouvrir et se fermer pour retirer et recouvrir à nouveau le revêtement avec une nouvelle pièce de recouvrement en cuir une fois que l'ancienne protection en cuir est portée.
Patent WO-2008028199-A1 (WO)
Title: Système de fermeture et procédé associé
Inventor: HALL KENNETH MICHAEL
IPC: B05B11/00
Filed: 2007-08-27
Abstract: L'invention concerne un conteneur aérosol (10) pourvue d'une partie col (12) dont l'épaisseur de paroi est la même que celle du reste du conteneur et possède une surface intérieure (14), une surface extérieure (16) et une ouverture (18). Un capuchon (20) possède un retrait interne (22) qui est défini par une zone d'épaulement (24) qui possède une zone opposée au retrait interne (26) et une surface opposée (28) à la partie col (12). Une zone supplémentaire (27) du capuchon (20) est située sur l'extérieur de ce dernier et forme un manchon (29) qui, en utilisation, chevauche la surface extérieure (16) de la partie col (12). Le capuchon (20) est formé en acier déformable. L'invention concerne également un anneau (30) d'acier. Un joint (40) est formé de matériau déformable flottant. En utilisation, l'anneau (30) est placé sur la surface extérieure (16) de la partie col (12) et vient s'adapter à cette dernière. Le joint (40) est placé entre le capuchon (20) et la partie col (12). Le capuchon (20) est ensuite placé sur l'ouverture (18) du conteneur (10) et le retrait (22) est positionné dans l'ouverture (18) de sorte que la surface (28) de la zone d'épaulement (24) chevauche et soit opposée à la surface intérieure (14).
Patent DK-201700570-A1 (DK)
Title: Column photobioreactor
Inventor: Francisco Javier Navas Martos
IPC: B01J19/12
Filed: 2017-10-11
Abstract: A tubular photobioreactor for production of photosynthetic microorganisms is devised. The reactor comprises a growth module, consisting of vertical, transparent tubes, mounted between two circular manifolds. Flow direction is in all transparent tubes is vertically ascending. Flow is recirculated in a closed loop to the lower manifold with a pump. Oxygen is removed in an additional loop in a central degasser column that also functions as structural support of the reactor. The degasser applies a falling-film degassing principle. Advantages of the photobioreactor is low mixing- and mass transfer energy costs; all tube and manifold connections assembled in a single factory supplied growth module, which makes the reactor economic; the vertical orientation of the tubes furthermore provides a more photosynthetically efficient use of the absorbed daily solar irradiation.
Patent DK-201800834-A1 (DK)
Title: Flybord med et monteringsarrangement, der er indrettet til at udvide flybordet med et ekstra bord
Inventor: HEINO JAKOBSEN
IPC: B64D11/06
Filed: 2018-11-07
Abstract: Med henblik på at forøge pladsen af et flybords overflade, er der ifølge opfindelsen tilvejebragt et ekstra bord, som er indrettet til at blive monteret i det hul der opstår når flybordet fra en position hvor det ligger an mod flysædets ryg til, efter en drejning af flybordet til en vandret position, som indebærer, at der opstår et hul mellem flysædets ryg og flybordet når flybordet er i vandret position, er der ifølge opfindelsen anordnet en monteringsstang som er anordnet nær den kant af flybordet der vender mod flysædet ryg. På denne monteringsstang, som kan være rund eller mangekantet, kan der monteres forbindelseselementer, der er indrettet til at optage en glideskinne der har en rille hvori et ekstra bord, der er L-formet kan anbringes i rillen, idet det er den korte side i L’et der anbringes i rillen.
Patent PH-12013000303-A1 (PH)
Title: Counter rotating wind turbine generator in the perimeter
Inventor: ESTADOLA KARL IVAN
IPC: F03D1/06
Filed: 2013-10-10
Abstract: The present invention relates to a wind turbine machine comprising a supporting means, a pair of spaced apart counter rotatable front and rear rotors being rotatably supported on said supporting means, said front and rear rotors being adapted to counter rotate correspondingly to a first and second wind loads, a plurality of spaced apart front and rear blades being rotatably secured correspondingly within said front and rear rotors, a generator means being provided between of said front and rear rotors, and a blade pitching means being configured to operate on said front and rear rotors and said blades to control the speed of rotation of said front and rear rotors. The front rotor has a tunneling mechanism directly coupled to the front rotor and a diffuser mechanism for the rear rotor. The blades are made of hollow inflatable materials filled with air with pitching mechanism, making the present invention lighter than the conventional blades design.
Patent PH-12015501074-A1 (PH)
Title: Triazolopyrazine
Inventor: HARALD ENGELHARDT
IPC: C07D519/00
Filed: 2015-05-14
Abstract: The present invention encompasses compounds of general formula (I) wherein the groups R1 to R 3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
Patent PH-12017500356-A1 (PH)
Title: Structure for front portion of vehicle
Inventor: TOKIZANE RYO
IPC: B60R19/18
Filed: 2017-02-27
Abstract: A structure for the front portion of a vehicle comprises: a front bumper cross member 4 constituting a front bumper; an energy absorption member 5 having a polygonal closed cross-sectional shape, the energy absorption member 5 being affixed to the front face of the front bumper cross member 4 and crushing during a frontal collision of the vehicle; a female thread member 43 provided on the front face section of the front bumper cross member 4, the female thread member 43 having a bolt 53 engaged therewith, the bolt 53 having been passed through the energy absorption member 5, the female thread member 43 affixing the energy absorption member 5 to the front bumper cross member 4; a protrusion 51a2 formed protruding from the front bumper cross member 4-side mounting surface of the energy absorption member 5 toward the front bumper cross member 4 by a height greater than that of the head 53a of the bolt 53, the protrusion 51a2 receiving the head 53a of the bolt 53; and a recess 41a1 formed on the front face side of the front bumper cross member 4 and receiving the protrusion 51a2.
Patent PH-12017501769-A1 (PH)
Title: Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
Inventor: KIM YONG IL
IPC: A61K31/4422
Filed: 2017-09-26
Abstract: The present invention provides a pharmaceutical complex formulation comprising a first mixture including amlodipine and chlorthalidone and a second mixture including losartan, which has an improved dissolution and stability. The complex formulation according to the present invention may achieve improved preventive or therapeutic effects for cardiovascular diseases by actuating different mechanism of amlodipine, losartan and chlorthalidone, and exhibits high dissolution rates of amlodipine, losartan and chlorthalidone and improved storage stability, due to the minimized drug interactions, and therefore, it is useful in the fields of pharmaceuticals and medicine.
Patent PH-12017502346-A1 (PH)
Title: Odor free volatile fatty acids as an energy source for ruminants, swine and poultry
Inventor: STARK PETER A
IPC: A23K50/75
Filed: 2017-12-18
Abstract: This invention overcomes the odor problems of volatile isoacids as energy sources for ruminants, swine and poultry, and combines the advantages of sugars and macro minerals such as, calcium and magnesium, by preparing feed supplements from polycarboxylic acid metal salts. Preferably, calcium and magnesium with pendant polycarboxylic acid groups from readily available materials, such as pectin, to provide low odor ruminant milk enhancers that are effective, easy to make and use.
Patent PH-12019502515-A1 (PH)
Title: Security devices and methods for their manufacture
Inventor: MUNDY DARRYL
IPC: B42D25/387
Filed: 2019-11-08
Abstract: A security device is disclosed, comprising: a first ink (21) and a second ink (22) each arranged in respective laterally offset first and second regions of the security device, the first and second inks each comprising a respective luminescent material which both luminesce in response to irradiation at at least one excitation wavelength in the ultra-violet spectrum, the first and second inks each exhibiting substantially the same non-luminescent visible colour as one another when illuminated with visible light in the absence of the at least one excitation wavelength, and the first and second inks each exhibiting visible colours which are different from the non-luminescent visible colour and from one another when illuminated with a combination of visible light and the at least one excitation wavelength; a third ink (23) arranged in a third region of the device laterally offset from the first and second regions of the device, the third ink not luminescing in response to the at least one excitation wavelength, and the third ink exhibiting substantially the same non-luminescent visible colour as the first and second inks when illuminated with visible light in the absence of the at least one excitation wavelength; and a fourth ink (24) arranged in a masking pattern which partially overlaps one or more portions of the first ink in the first region and/or of the second ink in the second region, the fourth ink not luminescing in response to the at least one excitation wavelength, and the fourth ink exhibiting a different visible colour from the non-luminescent visible colour of the first, second and third inks when illuminated with visible light in the absence of the at least one excitation wavelength. When the security device is illuminated with visible light in the absence of the at least one excitation wavelength, the first, second and third regions together appear as one continuous pattern in the non-luminescent visible colour, the fourth ink obscuring the presence of more than one ink forming the continuous pattern, and when the security device is illuminated with a combination of visible light and the at least one excitation wavelength, the first and second regions become visibly distinct from each other and from the remainder of the continuous pattern.
Patent PH-12020551939-A1 (PH)
Title: Pharmaceutical composition comprising sglt-2 inhibitor and dpp-iv inhibitor
Inventor: LEE JUNG-HWAN
IPC: A61P3/10
Filed: 2020-11-13
Abstract: The present invention relates to a pharmaceutical composition comprising dapagliflozin or a pharmaceutically acceptable salt, hydrate, or solvate thereof; linagliptin or a pharmaceutically acceptable salt, hydrate, or solvate thereof; and an excipient, and a preparation method therefor. The pharmaceutical composition enhances a therapeutic effect on non-insulin dependent diabetes mellitus, with reduced side effects, and secure equivalent dissolution rates and non-clinical equivalence to respective agents including individual ingredients. The composition allows the minimization of tablet sizes and enhances the stability of product quality, as well, thereby improving patient's convenience for drug intake, and drug compliance. Therefore, the composition can be advantageously used as an effective prophylatic or therapeutic agent for non-insulin dependent diabetes mellitus.
Patent PH-12021550024-A1 (PH)
Title: Anthelminthic heterocyclic compounds
Inventor: LONG ALAN
IPC: C07D471/04
Filed: 2021-01-05
Abstract: A compound of formula (I), (IA) or formula (II) or a composition comprising the compound of formula (I), (IA) or formula (II) in association with a veterinarily acceptable carrier are described. A method of controlling helminths using same is described.
Patent DE-102004001801-A1 (DE)
Title: System and process for the dialog between man and machine considers human emotion for its automatic answers or reaction
Inventor: RUNGE FRED
IPC: G06F3/16
Filed: 2004-01-05
Abstract: The invention relates to patient (10) machine interaction. The aim of the invention is not only to transmit facts via a data connection but to also take human emotions into consideration. The machine adjusts its reaction according to the expressed human emotions and therefore makes a more confident expression. The emotions are detected by means of a video camera, a microphone or bio-sensors measuring pulse, breathing, blood pressure, brain activity, body temperature, skin resistivity and/or the dynamic of a location change. The sensor signals are digitized in the end device (20) and then transmitted to the server system via the communication system. The measured signals are processed in the server system, corresponding characteristics are being extracted and further data is added in parallel. The system can detect if a patient is tensed, relaxed, afraid, tired, happy, angry, aggressive, depressed, sad or bored. By determining the state of the patient the system evaluates the approach on how to communicate e.g. calming the patient down or reassuring the patient.